PureTech Health (PRTC) Competitors $21.70 +0.44 (+2.07%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PRTC vs. APGE, MIRM, CNTA, EVO, IRON, HRMY, NAMS, RXRX, TARS, and GLPGShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Apogee Therapeutics (APGE), Mirum Pharmaceuticals (MIRM), Centessa Pharmaceuticals (CNTA), Evotec (EVO), Disc Medicine (IRON), Harmony Biosciences (HRMY), NewAmsterdam Pharma (NAMS), Recursion Pharmaceuticals (RXRX), Tarsus Pharmaceuticals (TARS), and Galapagos (GLPG). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Apogee Therapeutics Mirum Pharmaceuticals Centessa Pharmaceuticals Evotec Disc Medicine Harmony Biosciences NewAmsterdam Pharma Recursion Pharmaceuticals Tarsus Pharmaceuticals Galapagos PureTech Health (NASDAQ:PRTC) and Apogee Therapeutics (NASDAQ:APGE) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends. Which has more volatility and risk, PRTC or APGE? PureTech Health has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500. Comparatively, Apogee Therapeutics has a beta of 2.93, suggesting that its stock price is 193% more volatile than the S&P 500. Do institutionals & insiders have more ownership in PRTC or APGE? 0.0% of PureTech Health shares are held by institutional investors. Comparatively, 79.0% of Apogee Therapeutics shares are held by institutional investors. 5.3% of PureTech Health shares are held by insiders. Comparatively, 36.1% of Apogee Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend PRTC or APGE? PureTech Health currently has a consensus price target of $45.00, suggesting a potential upside of 107.42%. Apogee Therapeutics has a consensus price target of $78.50, suggesting a potential upside of 74.29%. Given PureTech Health's stronger consensus rating and higher probable upside, equities analysts plainly believe PureTech Health is more favorable than Apogee Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Apogee Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor PRTC or APGE? Apogee Therapeutics received 9 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 100.00% of users gave Apogee Therapeutics an outperform vote while only 45.00% of users gave PureTech Health an outperform vote. CompanyUnderperformOutperformPureTech HealthOutperform Votes945.00% Underperform Votes1155.00% Apogee TherapeuticsOutperform Votes18100.00% Underperform VotesNo Votes Does the media favor PRTC or APGE? In the previous week, Apogee Therapeutics had 8 more articles in the media than PureTech Health. MarketBeat recorded 10 mentions for Apogee Therapeutics and 2 mentions for PureTech Health. PureTech Health's average media sentiment score of 1.42 beat Apogee Therapeutics' score of 0.14 indicating that PureTech Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PureTech Health 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apogee Therapeutics 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is PRTC or APGE more profitable? PureTech Health's return on equity of 0.00% beat Apogee Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A N/A N/A Apogee Therapeutics N/A -21.81%-20.94% Which has higher valuation & earnings, PRTC or APGE? PureTech Health has higher revenue and earnings than Apogee Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health$3.33M155.97-$65.70MN/AN/AApogee TherapeuticsN/AN/A-$83.99M-$2.42-18.61 SummaryPureTech Health beats Apogee Therapeutics on 8 of the 15 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$508.96M$6.48B$5.05B$8.81BDividend YieldN/A8.12%4.97%4.06%P/E RatioN/A5.5697.3417.77Price / Sales155.97348.141,218.4275.18Price / CashN/A22.1533.5132.53Price / Book1.287.885.804.68Net Income-$65.70M$153.61M$119.07M$226.08M7 Day Performance-1.07%-2.00%-1.83%-1.04%1 Month Performance5.83%-7.47%-3.64%1.04%1 Year Performance-0.39%31.80%31.62%26.28% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health2.2347 of 5 stars$21.70+2.1%$45.00+107.4%+0.9%$508.96M$3.33M0.00100News CoveragePositive NewsAPGEApogee Therapeutics2.241 of 5 stars$45.04-3.2%$78.50+74.3%+149.9%$2.03BN/A-18.6191MIRMMirum Pharmaceuticals4.2959 of 5 stars$43.69+3.8%$57.73+32.1%+36.1%$2.02B$186.37M0.00140Analyst RevisionCNTACentessa Pharmaceuticals4.0515 of 5 stars$16.74-0.5%$25.83+54.3%+144.7%$1.90B$6.85M-10.9472EVOEvotec1.7338 of 5 stars$5.30+2.9%$5.93+11.9%-49.7%$1.88B$845.74M0.005,061HRMYHarmony Biosciences4.7841 of 5 stars$32.79+1.0%$47.00+43.3%+18.1%$1.87B$582.02M15.39200IRONDisc Medicine3.1622 of 5 stars$62.55+5.0%$85.80+37.2%+22.4%$1.86BN/A-15.7278Insider TradeAnalyst RevisionNAMSNewAmsterdam Pharma2.936 of 5 stars$20.01-15.5%$33.80+68.9%+110.6%$1.85B$33.59M0.0057Insider TradeNews CoverageGap DownHigh Trading VolumeRXRXRecursion Pharmaceuticals1.9932 of 5 stars$6.04-3.7%$9.25+53.1%-12.0%$1.80B$44.58M0.00400Analyst ForecastOptions VolumeHigh Trading VolumeTARSTarsus Pharmaceuticals1.8691 of 5 stars$46.58-0.7%$54.20+16.4%+166.2%$1.79B$17.45M-12.2350Analyst RevisionGLPGGalapagos1.2816 of 5 stars$25.64-3.9%$30.75+19.9%-31.4%$1.69B$259.40M0.001,123Analyst DowngradeShort Interest ↓Gap DownHigh Trading Volume Related Companies and Tools Related Companies APGE Alternatives MIRM Alternatives CNTA Alternatives EVO Alternatives IRON Alternatives HRMY Alternatives NAMS Alternatives RXRX Alternatives TARS Alternatives GLPG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRTC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTC Stock Alerts